Free Trial

Iradimed Q4 2024 Earnings Report

Iradimed logo
$52.45 +1.01 (+1.96%)
As of 03/14/2025 04:00 PM Eastern

Iradimed EPS Results

Actual EPS
$0.40
Consensus EPS
$0.45
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Iradimed Revenue Results

Actual Revenue
$19.39 million
Expected Revenue
$19.09 million
Beat/Miss
Beat by +$300.00 thousand
YoY Revenue Growth
N/A

Iradimed Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Remove Ads

Iradimed Earnings Headlines

Iradimed (NASDAQ:IRMD) Rating Lowered to Buy at StockNews.com
Elon Warns “America Is Broke”. Trump’s Plan Inside.
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...
See More Iradimed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Iradimed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Iradimed and other key companies, straight to your email.

About Iradimed

Iradimed (NASDAQ:IRMD) Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

View Iradimed Profile

More Earnings Resources from MarketBeat